Citation: Rap. Koene et Lb. Hilbrands, CHOICES OF LONG-TERM IMMUNOSUPPRESSION IN RENAL-TRANSPLANTATION - BALANCING THE BENEFITS AND RISKS, Nephrology, dialysis, transplantation, 13(4), 1998, pp. 844-846
Citation: Ajw. Branten et al., RENAL AND SYSTEMIC EFFECTS OF ATENOLOL AND TERTATOLOL IN RENAL-TRANSPLANT RECIPIENTS ON CYCLOSPORINE-A, Nephrology, dialysis, transplantation, 13(2), 1998, pp. 423-426
Citation: Pwg. Dubufvereijken et al., PARTIAL RENAL-VEIN THROMBOSIS IN A KIDNEY-TRANSPLANT - MANAGEMENT BY STREPTOKINASE AND HEPARIN, Nephrology, dialysis, transplantation, 13(2), 1998, pp. 499-502
Authors:
HILBRANDS LB
WETZELS JFM
HOITSMA AJ
KOENE RAP
Citation: Lb. Hilbrands et al., CYCLOSPORINE DOES NOT INHIBIT THE TUBULAR SECRETION OF CREATININE, Nephrology, dialysis, transplantation, 11(5), 1996, pp. 833-836
Authors:
HILBRANDS LB
HOITSMA AJ
WETZELS JFM
KOENE RAP
Citation: Lb. Hilbrands et al., DETAILED STUDY OF CHANGES IN RENAL-FUNCTION AFTER CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE, Clinical nephrology, 45(4), 1996, pp. 230-235
Citation: Lb. Hilbrands et al., RANDOMIZED, PROSPECTIVE TRIAL OF CYCLOSPORINE MONOTHERAPY VERSUS AZATHIOPRINE-PREDNISONE FROM 3 MONTHS AFTER RENAL TRANSPLANTATION, Transplantation, 61(7), 1996, pp. 1038-1046
Citation: Ajw. Branten et al., SYSTEMIC AND RENAL HEMODYNAMIC-EFFECTS OF TERTATOLOL AND ATENOLOL IN RENAL-TRANSPLANT RECIPIENTS ON CYCLOSPORINE-A, Journal of the American Society of Nephrology, 6(3), 1995, pp. 1074-1074
Citation: Lb. Hilbrands et al., THE EFFECTS OF CYCLOSPORINE AND PREDNISONE ON SERUM-LIPID AND (APO)LIPROPROTEIN LEVELS IN RENAL-TRANSPLANT RECIPIENTS, Journal of the American Society of Nephrology, 5(12), 1995, pp. 2073-2081
Citation: Ajw. Branten et al., SYSTEMIC AND RENAL HEMODYNAMIC-EFFECTS OF TERTATOLOL AND ATENOLOL IN RENAL-TRANSPLANT RECIPIENTS ON CYCLOSPORINE-A, Kidney international, 48(4), 1995, pp. 1365-1366
Citation: Lb. Hilbrands et al., THE EFFECT OF IMMUNOSUPPRESSIVE DRUGS ON QUALITY-OF-LIFE AFTER RENAL-TRANSPLANTATION, Transplantation, 59(9), 1995, pp. 1263-1270
Citation: Lb. Hilbrands et al., EFFECT OF IMMUNOSUPPRESSIVE THERAPY ON QUALITY-OF-LIFE AFTER RENAL-TRANSPLANTATION, Journal of the American Society of Nephrology, 5(3), 1994, pp. 1011-1011
Citation: Lb. Hilbrands et al., ACUTE EFFECTS OF NIFEDIPINE IN RENAL-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE OR AZATHIOPRINE, American journal of kidney diseases, 24(5), 1994, pp. 838-845
Authors:
VANWEZEL HBM
HILBRANDS LB
KOENE RAP
HOITSMA AJ
Citation: Hbm. Vanwezel et al., CONVERSION FROM CYCLOSPORINE TO AZATHIOPRINE AT 3 MONTHS AFTER RENAL-TRANSPLANTATION - LONG-TERM RESULTS, Transplantation proceedings, 26(5), 1994, pp. 2550-2552
Authors:
MERKUS JWS
VANASTEN WNJC
HILBRANDS LB
HOITSMA AJ
KOENE RAP
SKOTNICKI SH
Citation: Jws. Merkus et al., COMPUTER-SIMULATIONS IN COMPARISON WITH IN-VIVO MEASUREMENTS OF NIFEDIPINE-INDUCED CHANGES IN RENAL-ALLOGRAFT HEMODYNAMICS, Journal of ultrasound in medicine, 12(9), 1993, pp. 517-523
Authors:
HILBRANDS LB
HOITSMA AJ
DEMACKER PNM
KOENE RAP
Citation: Lb. Hilbrands et al., EFFECT OF IMMUNOSUPPRESSIVE THERAPY ON SERUM-LIPID LEVELS AFTER RENAL-TRANSPLANTATION, Kidney international, 44(5), 1993, pp. 1198-1198